{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:14:31Z","timestamp":1773285271215,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T00:00:00Z","timestamp":1502668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00192-017-3440-2","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T10:24:44Z","timestamp":1502706284000},"page":"1005-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["What is the true catheterization rate after intravesical onabotulinumtoxinA injection?"],"prefix":"10.1007","volume":"29","author":[{"given":"Devin N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juzar","family":"Jamnagerwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Houman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn S.","family":"Eilber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"issue":"1","key":"3440_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213\u201340.","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"3440_CR2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMcp1003849","volume":"363","author":"I Nygaard","year":"2010","unstructured":"Nygaard I. Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med. 2010;363(12):1156\u201362.","journal-title":"N Engl J Med"},{"issue":"6 Suppl","key":"3440_CR3","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","volume":"188","author":"EA Gormley","year":"2012","unstructured":"Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline. J Urol. 2012;188(6 Suppl):2455\u201363.","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"3440_CR4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00005392-200009010-00018","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164(3 Pt 1):692\u20137.","journal-title":"J Urol"},{"issue":"1","key":"3440_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","volume":"180","author":"L Brubaker","year":"2008","unstructured":"Brubaker L, Richter HE, Visco A, Mahajan S, Nygaard I, Braun TM, et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol. 2008;180(1):217\u201322.","journal-title":"J Urol"},{"issue":"3","key":"3440_CR6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol. 2005;174(3):984\u20139.","journal-title":"J Urol"},{"issue":"6","key":"3440_CR7","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","volume":"189","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013;189(6):2186\u201393.","journal-title":"J Urol"},{"issue":"2","key":"3440_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","volume":"64","author":"C Chapple","year":"2013","unstructured":"Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64(2):249\u201356.","journal-title":"Eur Urol"},{"issue":"19","key":"3440_CR9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","volume":"367","author":"AG Visco","year":"2012","unstructured":"Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, et al. Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence. N Engl J Med. 2012;367(19):1803\u201313.","journal-title":"N Engl J Med"},{"issue":"6","key":"3440_CR10","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.juro.2009.08.031","volume":"182","author":"NY Siddiqui","year":"2009","unstructured":"Siddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol. 2009;182(6):2799\u2013804.","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"3440_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(05)00326-5","volume":"175","author":"M Brazzelli","year":"2006","unstructured":"Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175(3 Pt 1):835\u201341.","journal-title":"J Urol"},{"issue":"13","key":"3440_CR12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.2016.14617","volume":"316","author":"CL Amundsen","year":"2016","unstructured":"Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316(13):1366\u201374.","journal-title":"JAMA"},{"issue":"3","key":"3440_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","volume":"28","author":"BL Cohen","year":"2009","unstructured":"Cohen BL, Barboglio P, Rodriguez D, Gousse AE. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn. 2009;28(3):205\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"3440_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","volume":"44","author":"T Leippold","year":"2003","unstructured":"Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol. 2003;44(2):165\u201374.","journal-title":"Eur Urol"},{"issue":"4","key":"3440_CR15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","volume":"61","author":"C Dowson","year":"2012","unstructured":"Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A. Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. Eur Urol. 2012;61(4):834\u20139.","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"3440_CR16","first-page":"1359","volume":"178","author":"HC Kuo","year":"2007","unstructured":"Kuo HC. Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin A for idiopathic detrusor overactivity. J Urol. 2007;178(4 Pt 1):1359\u201363.","journal-title":"J Urol"},{"issue":"2","key":"3440_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0974-7796.82170","volume":"3","author":"W Altaweel","year":"2011","unstructured":"Altaweel W, Mokhtar A, Rabah DM. Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder. Urol Ann. 2011;3(2):66\u201370.","journal-title":"Urol Ann"},{"issue":"5","key":"3440_CR18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","volume":"61","author":"RP Manecksha","year":"2012","unstructured":"Manecksha RP, Cullen IM, Ahmad S, McNeill G, Flynn R, McDermott TE, et al. Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. Eur Urol. 2012;61(5):928\u201335.","journal-title":"Eur Urol"},{"issue":"3","key":"3440_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.eururo.2011.12.056","volume":"62","author":"DG Tincello","year":"2012","unstructured":"Tincello DG, Kenyon S, Abrams KR, Mayne C, Toozs-Hobson P, Taylor D, et al. Botulinum toxin A versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). Eur Urol. 2012;62(3):507\u201314.","journal-title":"Eur Urol"},{"issue":"6","key":"3440_CR20","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","volume":"181","author":"MK Flynn","year":"2009","unstructured":"Flynn MK, Amundsen CL, Perevich M, Liu F, Webster GD. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol. 2009;181(6):2608\u201315.","journal-title":"J Urol"},{"issue":"1","key":"3440_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11255-011-9979-9","volume":"44","author":"P Kanagarajah","year":"2012","unstructured":"Kanagarajah P, Ayyathurai R, Caruso DJ, Gomez C, Gousse AE. Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity. Int Urol Nephrol. 2012;44(1):91\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"3440_CR22","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.clinthera.2012.10.006","volume":"34","author":"B Pinder","year":"2012","unstructured":"Pinder B, Lloyd AJ, Elwick H, Denys P, Marley J, Bonniaud V. Development and psychometric validation of the intermittent self-catheterization questionnaire. Clin Ther. 2012;34(12):2302\u201313.","journal-title":"Clin Ther"},{"issue":"1","key":"3440_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/nau.20610","volume":"28","author":"TM Kessler","year":"2009","unstructured":"Kessler TM, Ryu G, Burkhard FC. Clean intermittent self-catheterization: a burden for the patient? Neurourol Urodyn. 2009;28(1):18\u201321.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"3440_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1464-410X.1990.tb14653.x","volume":"65","author":"RJ Webb","year":"1990","unstructured":"Webb RJ, Lawson AL, Neal DE. Clean intermittent self-catheterisation in 172 adults. Br J Urol. 1990;65(1):20\u20133.","journal-title":"Br J Urol"},{"issue":"10","key":"3440_CR25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.sc.3101348","volume":"40","author":"JJ Wyndaele","year":"2002","unstructured":"Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord. 2002;40(10):536\u201341.","journal-title":"Spinal Cord"},{"issue":"6","key":"3440_CR26","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol. 2007;177(6):2231\u20136.","journal-title":"J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-017-3440-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-017-3440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-017-3440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T05:52:55Z","timestamp":1529128375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-017-3440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3440"],"URL":"https:\/\/doi.org\/10.1007\/s00192-017-3440-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]}}}